Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More General business news Why Beijing’s central bank won’t budge on rates even as growth falters China keeps lending rates unchanged for the fourth month despite weak growth. Discover why the PBOC is cautious and what this means for global markets. byPallavi MadhirajuSeptember 22, 2025